Status:
COMPLETED
Patient and Physician Survey Determinants of Appropriate ICD Utilization
Lead Sponsor:
Todd M Koelling, MD
Collaborating Sponsors:
Medtronic
Conditions:
Heart Failure, Systolic
Eligibility:
All Genders
18+ years
Brief Summary
To better understand the reasons for underutilization of defibrillator therapy in selected populations, the investigators propose a study to assess heart failure patient knowledge and attitudes toward...
Detailed Description
Several multi-center randomized trials have demonstrated the benefit of implantable cardioverter defibrillators (ICDs) for the primary prevention of sudden cardiac death among patients with ischemic a...
Eligibility Criteria
Inclusion
- Age ≥ 18 years old
- Left ventricular ejection fraction ≤ 35%
- Previous diagnosis of heart failure with current NYHA Class II-III symptoms
- Established UMHS patient with at least two outpatient visits in the past two years to either Primary Care or Cardiology, OR, at least one inpatient admission in the past two years along with at least one outpatient visit within the past 13 months to Primary Care or Cardiology
Exclusion
- Patients having undergone heart transplantation
- Patients having undergone placement of a left ventricular assist device
- Patients with congenital heart disease
Key Trial Info
Start Date :
August 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 30 2013
Estimated Enrollment :
452 Patients enrolled
Trial Details
Trial ID
NCT01514773
Start Date
August 1 2011
End Date
August 30 2013
Last Update
March 17 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan Health System
Ann Arbor, Michigan, United States, 48109